Role of intramolecular epitope spreading in pemphigus vulgaris

Clinical Immunology

Volumn 116, Issue 1, 2005, Pages 54-64

  Salato, Valerie K ^a   Hacker Foegen, Mary K ^a   Lazarova, Zelmira ^a   Fairley, Janet A ^a,b   Lin, Mong Shang ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b CLEMENT J ZABLOCKI VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Adhesion molecules; Autoantibodies; Autoimmunity; Immunobullous disease; Skin

Indexed keywords

AUTOANTIBODY; GLYCOPROTEIN; GLYCOPROTEIN DSG 3; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; EPITOPE MAPPING; HUMAN; HUMAN TISSUE; MOLECULAR MECHANICS; MUCOSA; NONHUMAN; PATHOGENESIS; PEMPHIGUS VULGARIS; PRIORITY JOURNAL; PROTEIN DOMAIN;

AUTOANTIBODIES; CADHERINS; DESMOGLEIN 3; EPITOPES; HUMANS; PEMPHIGUS; PEPTIDE FRAGMENTS; PROTEIN STRUCTURE, TERTIARY; SKIN;

EID: 19544373821     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2005.03.005     Document Type: Article

References (40)

1. W.F. Lever Pemphigus vulgaris W.F. Lever Pemphigus and pemphigoid 1965 Charles C. Thomas Springfield
2. M.S. Lin, J.M. Mascaro Jr., Z. Liu, A. Espana, and L.A. Diaz The desmosome and hemidesmosome in cutaneous autoimmunity Clin. Exp. Immunol. 107 1997 9 15
3. X. Ding, L.A. Diaz, J.A. Fairley, G.J. Giudice, and Z. Liu The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic J. Invest. Dermatol. 112 1999 739 743
4. G.J. Anhalt, R.S. Labib, J.J. Vorhees, T.F. Beals, and L.A. Diaz Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease N. Engl. J. Med. 306 1982 1189 1196
5. M. Amagai, S. Karpati, R. Prussick, V. Kalus-Kovtun, and J.R. Stanley Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic J. Clin. Invest. 90 1992 919 926
6. M. Amagai, V. Klaus-Kovtun, and J.R. Stanley Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion Cell 67 1991 869 877
7. N.J. Korman, R.W. Eyre, V. Klaus-Kovtun, and J.R. Stanley Demonstration of an adhering-junction molecule (Plakoglobin) in the autoantigens of pemphigus foliaceus and pemphigus vulgaris N. Engl. J. Med. 321 1989 631 635
8. R. Kemler From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion Trends Genet. 9 1993 317 321
9. C. Marcozzi, I.D. Burdett, R.S. Buxton, and A.I. Magee Coexpression of both types of desmosomal cadherin and plakoglobin confers strong intercellular adhesion J. Cell Sci. 111 1998 495 509
10. G.N. Wheeler, R.S. Buxton, A.E. Parker, J. Arnemann, D.A. Rees, I.A. King, and A.I. Magee Desmosomal glycoproteins I, II and III: novel members of the cadherin superfamily Biochem. Soc. Trans. 19 1991 1060 1064
11. M. Amagai, T. Hashimoto, N. Shimizu, and T. Nishikawa Absorption of pathogenic autoantibodies by the extracellular domain of pemphigus vulgaris antigen (Dsg3) produced by baculovirus J. Clin. Invest. 94 1994 59 67
12. L.A. Arteaga, P.S. Prisayanh, S.J.P. Warren, Z. Liu, L.A. Diaz, and M.S. Lin A subset of pemphigus foliaceus patients exhibits pathogenic autoantibodies against both desmoglein-1 and desmoglein-3 J. Invest. Dermatol. 118 2002 806 811
13. M. Amagai, S. Karpati, R. Prussick, V. Klaus-Kovtun, and J.R. Stanley Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic J. Clin. Invest. 90 1992 919 926
14. Y. Futei, M. Amagai, M. Sekiguchi, K. Nishifuji, Y. Fujii, and T. Nishikawa Use of domain-swapped molecules for conformational epitope mapping of desmoglein 3 in pemphigus vulgaris J. Invest. Dermatol. 115 2000 829 834
15. M. Sekiguchi, Y. Futei, Y. Fujii, T. Iwasaki, T. Nishikawa, and M. Amagai Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmoglein J. Immunol. 167 2001 5439 5448
16. K. Tsunoda, T. Ota, M. Aoki, T. Yamada, T. Nagai, T. Nakagawa, S. Koyasu, T. Nishikawa, and M. Amagai Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3 J. Immunol. 170 2003 2170 2178
17. S. Miyagawa, M. Amagai, T. Iida, Y. Yamamoto, T. Nishikawa, and T. Shirai Late development of anti-desmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression Br. J. Dermatol. 141 1999 1084 1087
18. K. Iwatsuki, M. Takigawa, T. Hashimoto, T. Nishikawa, and M. Yamada Can pemphigus vulgaris become pemphigus foliaceus? J. Am. Acad. Dermatol. 25 1991 797 800
19. S. Kawana, T. Hashimoto, T. Nishikawa, and S. Nishiyama Changes in clinical features, histologic findings, and antigen profiles with development of pemphigus foliaceus from pemphigus vulgaris Arch. Dermatol. 130 1994 1534 1538
20. G.N. Wheeler, A.E. Parker, C.L. Thomas, P. Ataliotis, D. Poynter, J. Arnemann, A.J. Rutman, S.C. Pidsley, F.M. Watt, D.A. Rees, R.S. Buxton, and A.I. Magee Desmosomal glycoprotein DGI, a component of intercellular desmosome junctions, is related to the cadherin family of cell adhesion molecules Proc. Natl. Acad. Sci. U. S. A. 88 1991 4796 4800
21. M.S. Lin, S.J. Swartz, A. Lopez, X. Ding, J.A. Fairley, and L.A. Diaz T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1 J. Invest. Dermatol. 109 1997 734 737
22. M. Amagai Autoimmunity against desmosomal cadherins in pemphigus J. Dermatol. Sci. 20 1999 92 102
23. J.R. Stanley The pathophysiology of pemphigus J. Dermatol. Sci. 24 2000 155 157
24. M.G. Mahoney, Z. Wang, K.L. Rothenberger, P.J. Koch, M. Amagai, and J.R. Stanley Explanation for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris J. Clin. Invest. 103 1999 461 468
25. M. Amagai, K. Tsunoda, D. Zillikens, T. Magai, and T. Nishikawa The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile J. Am. Acad. Dermatol. 40 1999 167 170
26. Y. Hanakawa, N. Matsuyoshi, and J.R. Stanley Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion J. Invest. Dermatol. 119 2002 27 31
27. H. Wu, Z.H. Wang, A. Yan, S. Lyle, S. Fakharzadeh, J.K. Wahl, M.J. Wheelock, M. Ishikawa, J. Uitto, M. Amagai, and J.R. Stanley Protection of neonates against pemphigus foliaceus by desmoglein 3 N. Engl. J. Med. 343 2000 31 35
28. X. Ding, V. Aoki, J.M. Mascaro Jr., A. Lopez-Swiderski, L.A. Diaz, and J.A. Fairley Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles J. Invest. Dermatol. 109 1997 592 596
29. M.K. Hacker, M. Jansen, J.A. Fairley, and M.S. Lin Isotype and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies Clin. Immunol. 105 2002 64 74
30. K. Ishii, M. Amagai, R.P. Hall, T. Hashimoto, A. Takayanagi, S. Gamou, N. Shimizu, and T. Nishikawa Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmoglein J. Immunol. 159 1997 2010 2017
31. K.-A. Netzer, A. Leinonen, A. Boutaud, D.-B. Borza, P. Todd, S. Gunwar, J.P.M. Langeveld, and B.G. Hudson The Goodpasture autoantigen. Mapping the major conformational epitope(s) of α(3IV) collagen to residues 17-31 and 127-141 of the NC1 domain J. Biol. Chem. 274 1999 11267 11274
32. P.V. Lehmann, T. Forsthuber, A. Miller, and E.E. Sercarz Spreading of T-cell autoimmunity to cryptic determinant of an autoantigen Nature 358 1992 155 157
33. D.L. Kaufman, M. Clare-Salzler, J. Tian, T. Forsthuber, G.S. Ting, P. Robinson, M.A. Atkinson, E.E. Sercarz, A.J. Tobin, and P.V. Lehmann Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes Nature 306 1993 69 72
34. C.L. Vanderlught, and S.D. Miller Epitope spreading in immune-mediated diseases: implication for immunotherapy Nat. Rev. 2 2002 85 95
35. L.S. Chan, C.J. Vanderlught, T. Hashimoto, T. Nishikawa, J.J. Zone, M.M. Black, F. Wojnarowska, S.R. Stevens, M. Chen, J.A. Fairley, D.T. Woodley, S.D. Miller, and K.B. Gordon Epitope spreading: lessons from autoimmune skin diseases J. Invest. Dermatol. 110 1998 103 109
36. B.I. McRae, C.L. Vanderlught, M.C. Dal Canto, and S.D. Miller Functional evidence for epitope spreading in the relapsing pathology of the experimental autoimmune encephalomyelitis J. Exp. Med. 182 1995 75 85
37. P. Söhnlein, M. Mûller, K. Syren, U. Hatmann, B.O. Böhm, H.M. Meinck, M. Knip, and H.K. Akerbom Epitope spreading and a varying but not disease-specific GAD65 antibody response in Type I diabetes Diabetologia 43 2000 210 217
38. E. Bonifacio, V. Lampasona, L. Bernasconi, and A.G. Ziegler Maturation of the humoral autoimmune response to epitopes of GAD in preclinical childhood type I diabetes Diabetes 49 2000 202 208
39. M.R. Arbuckle, M. Reichlin, J.B. Harley, and J.A. James Shared early autoantibody recognition events in the development of anti-Sm B/B′ in human lupus Scand. J. Immunol. 50 1999 447 455
40. N. Li, V. Aoki, G. Hans-Filho, E.A. Rivitti, and L.A. Diaz The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem) J. Exp. Med. 197 2003 1501 1510